These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19661299)

  • 1. Antiangiogenic properties of viscum album extracts are associated with endothelial cytotoxicity.
    Elluru SR; Duong Van Huyen JP; Delignat S; Prost F; Heudes D; Kazatchkine MD; Friboulet A; Kaveri SV
    Anticancer Res; 2009 Aug; 29(8):2945-50. PubMed ID: 19661299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis.
    Naumova E; Ubezio P; Garofalo A; Borsotti P; Cassis L; Riccardi E; Scanziani E; Eccles SA; Bani MR; Giavazzi R
    Clin Cancer Res; 2006 Mar; 12(6):1839-49. PubMed ID: 16551869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular-specific quantification in an in vivo Matrigel chamber angiogenesis assay.
    Baker JH; Huxham LA; Kyle AH; Lam KK; Minchinton AI
    Microvasc Res; 2006 Mar; 71(2):69-75. PubMed ID: 16545400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of apoptosis of endothelial cells by Viscum album: a role for anti-tumoral properties of mistletoe lectins.
    Duong Van Huyen JP; Bayry J; Delignat S; Gaston AT; Michel O; Bruneval P; Kazatchkine MD; Nicoletti A; Kaveri SV
    Mol Med; 2002 Oct; 8(10):600-6. PubMed ID: 12477970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel function of ascorbic acid as an angiostatic factor.
    Ashino H; Shimamura M; Nakajima H; Dombou M; Kawanaka S; Oikawa T; Iwaguchi T; Kawashima S
    Angiogenesis; 2003; 6(4):259-69. PubMed ID: 15166494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the antiangiogenic potential of AQ4N.
    O'Rourke M; Ward C; Worthington J; McKenna J; Valentine A; Robson T; Hirst DG; McKeown SR
    Clin Cancer Res; 2008 Mar; 14(5):1502-9. PubMed ID: 18316575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paediatric medulloblastoma cells are susceptible to Viscum album (Mistletoe) preparations.
    Zuzak TJ; Rist L; Eggenschwiler J; Grotzer MA; Viviani A
    Anticancer Res; 2006; 26(5A):3485-92. PubMed ID: 17094471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrigel cytometry: a novel method for quantifying angiogenesis in vivo.
    Adini A; Fainaru O; Udagawa T; Connor KM; Folkman J; D'Amato RJ
    J Immunol Methods; 2009 Mar; 342(1-2):78-81. PubMed ID: 19109967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice.
    Reinmuth N; Liu W; Ahmad SA; Fan F; Stoeltzing O; Parikh AA; Bucana CD; Gallick GE; Nickols MA; Westlin WF; Ellis LM
    Cancer Res; 2003 May; 63(9):2079-87. PubMed ID: 12727823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of the sensitivity of lymphoblastoid and transformed monocytic cell lines to the cytotoxic effects of Viscum album extracts of different origin.
    Duong Van Huyen JP; Delignat S; Kazatchkine MD; Kaveri SV
    Chemotherapy; 2003 Dec; 49(6):298-302. PubMed ID: 14671430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative effects of mistletoe (Viscum album L.) extract in urinary bladder carcinoma cell lines.
    Urech K; Buessing A; Thalmann G; Schaefermeyer H; Heusser P
    Anticancer Res; 2006; 26(4B):3049-55. PubMed ID: 16886633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic effects of the Viscum album L. extract on Ehrlich tumour cells in vivo.
    Cebović T; Spasić S; Popović M
    Phytother Res; 2008 Aug; 22(8):1097-103. PubMed ID: 18570233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-12 is associated with the in vivo anti-tumor effect of mistletoe extracts in B16 mouse melanoma.
    Duong Van Huyen JP; Delignat S; Bayry J; Kazatchkine MD; Bruneval P; Nicoletti A; Kaveri SV
    Cancer Lett; 2006 Nov; 243(1):32-7. PubMed ID: 16412563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-inducible protein 10 induction and inhibition of angiogenesis in vivo by the antitumor agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
    Cao Z; Baguley BC; Ching LM
    Cancer Res; 2001 Feb; 61(4):1517-21. PubMed ID: 11245459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-angiogenic efficacy of grape seed extract in endothelial cells.
    Agarwal C; Singh RP; Dhanalakshmi S; Agarwal R
    Oncol Rep; 2004 Mar; 11(3):681-5. PubMed ID: 14767522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin.
    Thaloor D; Singh AK; Sidhu GS; Prasad PV; Kleinman HK; Maheshwari RK
    Cell Growth Differ; 1998 Apr; 9(4):305-12. PubMed ID: 9563850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide.
    Ferrari N; Pfeffer U; Dell'Eva R; Ambrosini C; Noonan DM; Albini A
    Clin Cancer Res; 2005 Jun; 11(12):4610-9. PubMed ID: 15958647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An oriental herbal cocktail, ka-mi-kae-kyuk-tang, exerts anti-cancer activities by targeting angiogenesis, apoptosis and metastasis.
    Lee HJ; Lee EO; Rhee YH; Ahn KS; Li GX; Jiang C; Lü J; Kim SH
    Carcinogenesis; 2006 Dec; 27(12):2455-63. PubMed ID: 16777983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined anti-fetal liver kinase 1 monoclonal antibody and continuous low-dose doxorubicin inhibits angiogenesis and growth of human soft tissue sarcoma xenografts by induction of endothelial cell apoptosis.
    Zhang L; Yu D; Hicklin DJ; Hannay JA; Ellis LM; Pollock RE
    Cancer Res; 2002 Apr; 62(7):2034-42. PubMed ID: 11929822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.